BioSpace News Archive

Cardio Diagnostics Holdings, Inc, a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, announced the launch of the Company’s new integrated facility in Iowa City, Iowa.

ValGenesis, Inc. and Brevitas, an independent technology consulting firm, have partnered to introduce the ValGenesis product suite alongside Brevitas’ immense technical expertise in life sciences across the US and Canada.

Prime Therapeutics LLC and Magellan Rx Management LLC released the 13th annual Medical Pharmacy Trend Report™, featuring a comprehensive view of provider-administered medical benefit drug trends, the largest driver of specialty drug spend.

SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures has received their second FDA 510K clearance CommandEP™ adding a new integration.

Dermavant Announces New Positive Pruritus Data for VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as Two Years Old with Atopic Dermatitis at the EADV Congress 2023.

EndoSound, a pioneer in endoscopic ultrasound technology (EUS), and AdaptivEndo, a leader in single-use endoscopy solutions, are proud to announce their letter of intent to collaborate on a new groundbreaking project that aims to transform the landscape of endoscopy.

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress.

Aronora, Inc., a clinical-stage biotech poised to revolutionize blood clot treatment and prevention, today announced it has closed an investment from NYBC Ventures, a venture fund established by New York Blood Center.

DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes, related to its FLOW study that sought to demonstrate that Ozempic delays progression of chronic kidney disease (CKD) and lowers the risk of kidney and cardiovascular mortality.

Safety Shot, Inc. (Nasdaq: SHOT) today reported results from a product test of Safety Shot™, the world’s first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity.